EntryPoint Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,289
Closed -$412K 732
2025
Q4
$412K Buy
+3,289
New +$419K 0.16% 237
2025
Q2
Sell
-1,631
Closed -$216K 593
2025
Q1
$216K Sell
1,631
-1,891
-54% -$241K 0.1% 494
2024
Q4
$398K Buy
3,522
+1,406
+66% +$162K 0.17% 208
2024
Q3
$241K Buy
+2,116
New +$232K 0.14% 359
2024
Q2
Sell
-1,014
Closed -$115K 829
2024
Q1
$115K Buy
1,014
+647
+176% +$74.2K 0.1% 339
2023
Q4
$40.4K Buy
+367
New +$36.7K 0.04% 825

Other funds holding ABT

EntryPoint Capital's ABT Position: Q1 2026 in Review

EntryPoint Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 3,289 shares — an estimated $412K sold.

EntryPoint Capital first reported a position in ABT in Q4 2023 and held it in 6 quarters. The position peaked at $412K in Q4 2025. 3,085 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • EntryPoint Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • EntryPoint Capital sold 3,289 Abbott shares in Q1 2026, an estimated $412K.
  • EntryPoint Capital first reported a position in Abbott in Q4 2023 and held it in 6 quarters.
  • EntryPoint Capital's Abbott position peaked at $412K in Q4 2025.
  • 3,085 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.